Metrizamide myelography: blood and cerebrospinal fluid response.
Cerebrospinal fluid and blood were examined for immunologic factors before and after metrizamide myelography in 13 patients who underwent lumbar myelography and seven patients who underwent thoracic myelography. Clinical symptoms were also recorded. The results were consistent with a toxic reaction to the contrast medium, rather than an immunologic one.
D000293:Adolescent; D000328:Adult; D000906:Antibodies / Q000134:cerebrospinal fluid; D001769:Blood / Q000187:drug effects*; D001812:Blood-Brain Barrier / Q000187:drug effects; D002555:Cerebrospinal Fluid / Q000187:drug effects*; D002556:Cerebrospinal Fluid Proteins / Q000032:analysis; D005260:Female; D006801:Humans; D007074:Immunoglobulin G / Q000134:cerebrospinal fluid; D008297:Male; D008793:Metrizamide / Q000494:pharmacology*; D008875:Middle Aged; D009192:Myelography
D000906:Antibodies; D002556:Cerebrospinal Fluid Proteins; D007074:Immunoglobulin G; D008793:Metrizamide